Prevalence and Correlation of Cardiomyopathy in Type 2 Diabetes Mellitus Patients in South Rajasthan: A Prospective Observational Study
DOI:
https://doi.org/10.37506/5yh7xw93Keywords:
Diabetic cardiomyopathy, Type 2 diabetes mellitus, Echocardiography, Diastolic dysfunction, Cardiovascular complicationsAbstract
BackgroundDiabetes mellitus (DM) is a leading cause of cardiovascular morbidity and mortality worldwide. Among its cardiovascular complications, diabetic cardiomyopathy (DCM) is a distinct myocardial dysfunction occurring in diabetic patients without underlying coronary artery disease or hypertension. It manifests initially as diastolic dysfunction and progresses to heart failure if left undiagnosed and untreated. However, its early-stage detection remains a challenge due to the asymptomatic nature of the disease. This study aimed to determine the prevalence of DCM in Type 2 diabetes mellitus (T2DM) patients and evaluate its correlation with diabetes duration, lipid profile, and body mass index (BMI) in a tertiary care hospital in Rajasthan, India.
MethodsA prospective observational study was conducted at Maharana Bhupal Government Hospital, Udaipur, affiliated with R.N.T. Medical College, Rajasthan, involving 75 T2DM patients who underwent echocardiographic evaluation. Inclusion criteria included diagnosed cases of T2DM per ADA (2014) guidelines. Patients with ischemic heart disease, hypertension, and valvular heart disease were excluded. Echocardiography, lipid profile, HbA1c, and BMI were analyzed to assess the prevalence and risk factors associated with DCM. Statistical analysis was performed using SPSS v26.0, and results were interpreted using chi-square and t-tests.
ConclusionThe prevalence of DCM was 60%, with diastolic dysfunction as the predominant finding (75.5%). Significant associations were observed with higher BMI (p < 0.0001), HbA1c levels (p < 0.0001), and dyslipidemia (p < 0.05). The findings suggest that routine echocardiographic screening in asymptomatic diabetic patients is essential to identify and manage DCM early, preventing progression to heart failure and reducing mortality.
References
IDF diabetes atlas 2021 [Internet]. Diabetesatlas.org. [cited 2025 Feb 8]. Available from: https://diabetesatlas.org/atlas/tenth-edition/
Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015 Oct 10;6(13):1246-58.
Zhao X, Liu S, Wang X, Chen Y, Pang P, Yang Q, Lin J, Deng S, Wu S, Fan G, Wang B. Diabetic cardiomyopathy: Clinical phenotype and practice. Front Endocrinol (Lausanne). 2022 Dec 7;13:1032268.
Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia . 2014;57(4):660–71.
Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity: An update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624–38.
Seferović PM, Paulus WJ. Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J. 2015;36(27):1718–27, 1727a–1727c.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014 Jan;37 Suppl 1:S81-90.
Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association: A statement for healthcare professionals from the American heart association. Circulation. 1999;100(10):1134–46.
Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol. 2001;87(3):320–3.
Boyer JK, Thanigaraj S, Schechtman KB, Pérez JE. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol. 2004;93(7):870–5.
Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004;25(4):543–67.
Devereux RB, Roman MJ, Paranicas M, O’Grady MJ, Lee ET, Welty TK, et al. Impact of diabetes on cardiac structure and function: the strong heart study: The Strong Heart Study. Circulation. 2000;101(19):2271–6.
De Simone G, Devereux RB, Roman MJ, Chinali M, Okin PM, Daniels SR. Does cardiovascular risk factor burden explain the relation between diabetes and left ventricular mass? Hypertension. 2000;35(3):367–73.
Bell DS. Diabetic cardiomyopathy: a unique entity or a complication of coronary artery disease? Diabetes Care. 2003;26:2949–51.
Attali JR, Sachs RN, Valensi P, Palsky D, Tellier P, Vulpillat M, et al. Asymptomatic diabetic cardiomyopathy: a noninvasive study. Diabetes Res Clin Pract. 1988;4(3):183–90.
Kiencke S, Handschin R, Von Dahlen R, Muser M, Brunner-La Rocca HP, Schlapfer M. Preclinical diabetic cardiomyopathy: prevalence, screening, and outcome. Eur J Heart Fail. 2010;12(9):951–7.
Struthers AD, Morris AD. Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths? Lancet. 2000;355(9200):29–31.
Soininen P, Kangas AJ, Würtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 2015;8(1):192–206.
Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol [Internet]. 1991;68(1):85–9.
Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 2009;54(15):1407–24.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Kaptan Singh Yadav, Veeram Parmar, Radhey Sankhla, Siddharth Vijay Vergia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.